Princeton Pharmaceutical Company Obtains FDA Approval for Immunogenicity Simulator
The U.S. Food and Drug Administration announced Wednesday that it has cleared Certara's immunogenicity simulator to research and assess immunogenicity in protein-based therapies.
The Princeton-based leader in!-->!-->…